Новости медицинских изделий
Последние новости отрасли, изменения регулирования и объявления из надежных источников.
ARPA-H awards more than $100M to biosensor development projects
Four organizations will develop devices for tracking heart disease, inflammation and perimenopause.
Читать статью полностью →GE HealthCare agrees to acquire SOFIE Biosciences in $945m deal
The cash deal to acquire the PET radiopharmaceuticals CMO from Trilantic North America is expected to close in H1 2027. The post GE HealthCare agrees to acquire SOFIE Biosciences in $945m deal appeare…
Читать статью полностью →Autonomix secures Canadian patent for catheter-based technologies
Autonomix Medical has secured a new patent from the Canadian Intellectual Property Office covering its catheter-based tissue monitoring and therapy delivery technology. The post Autonomix secures Cana…
Читать статью полностью →Averly Health launches in UK to advance cardiometabolic care
Averly aims to improve patient care and access tenets surrounding cardiometabolic conditions, including obesity and type 2 diabetes. The post Averly Health launches in UK to advance cardiometabolic ca…
Читать статью полностью →First US commercial procedures completed with Emboline’s device
Emboline has reported the first commercial use of its Emboliner Embolic Protection System in the US during two procedures involving transcatheter aortic valve implantation. The post First US commercia…
Читать статью полностью →"The Next Signal": Where Commercial Pharma Data Is Headed
"The Next Signal": Where Commercial Pharma Data Is Headed dwunderlin Mon, 10/05/2026 - 14:28 Thu, 10/22/2026 - 14:00 Resource Type Webinar Amy Crowe Stephan Dunning, MBA, MS Commercial teams see patie…
Читать статью полностью →Регулируемый сердечный клапан для детей компании Edwards получил одобрение FDA
The device could help young patients avoid multiple open-heart surgeries as they grow, FDA officials said.
Читать статью полностью →FDA to prioritize guidance on AI, surgical robots next year
The FDA outlined its A-list and B-list guidance priorities for the 2027 fiscal year.
Читать статью полностью →